Dediabetes Logo
Evidence Hub
Learn what works
Latest Research
Newest studies
What Changed
Weekly intelligence
Settings
Login / Sign up

Metformin Therapies for Diabetes - Evidence Strength

Evidence on outcomes studied for Metformin

Evidence related to metformin therapies in diabetes studies.

15
Studies
49
Evidence Pairs
Limited Evidence
Evidence Strength: 45/100

Evidence summary for AI and search

Among 15 indexed studies and 3 interventions, the strongest signals are summarized from deterministic graph patterns. HbA1c appears to be one of the clearer current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.

Dediabetes summarizes indexed research evidence for education and discovery. This content is not medical advice and should not replace guidance from a qualified clinician.

Supporting Studies

15

Research documents analyzed

Evidence Pairs

49

Intervention-outcome relationships

Latest Publication

May 2026
Powered by the Dediabetes Evidence Intelligence™ framework

Evidence Snapshot

Qualitative overview of the evidence landscape

Low Confidence

Based on 15 studies, emerging evidence suggests HbA1c, Fasting Plasma Glucose (FPG), HDL cholesterol are the strongest-supported outcomes for metformin.

Evidence Intelligence™

Evidence Snapshot

A structured summary of where the evidence is strongest, mixed, or still emerging.

View all supporting studies

Evidence at a Glance

15
Studies
3
Interventions
40
Outcomes
0
Strong evidence signals
0
Mixed evidence areas
Evidence freshness
May 2026
Latest indexed
Evidence Story

Metformin evidence appears to center on HbA1c.

Among 15 indexed studies and 3 interventions, the strongest signals are summarized from deterministic graph patterns. HbA1c appears to be one of the clearer current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.
Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Freshness

Latest indexed evidence: May 2026

Key Finding

Evidence is consistently positive across multiple studies.

Interventions with strongest consistent evidence

Strongest consistent evidence

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

HbA1c appears to have a consistent beneficial signal in the indexed evidence.

View supporting studies
Evidence basis: 2 evidence pairs - 8 studies

Why this appears here

Moderate evidenceConsistent resultsPositive effect signalMultiple RCTs
HbA1c
8 studies
EvidenceScore™
62/100
ConsensusScore™
88/100

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

HbA1c is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

HbA1c
BMI
HbA1c
8 studies
EvidenceScore™
62/100
ConsensusScore™
88/100

Why this appears here

Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results Present
Evidence basis: 10 evidence pairs - 12 studies
View supporting studies
Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Fasting Plasma Glucose (FPG) may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

Fasting Plasma Glucose (FPG)
HDL cholesterol
Fasting Plasma Glucose (FPG)
2 studies
EvidenceScore™
57/100
ConsensusScore™
100/100

Why this appears here

Positive effect signalLimited study volumeEmerging Or Limited StrengthFew randomized trials
Evidence basis: 6 evidence pairs - 4 studies
View supporting studies

Practical Questions

Organized using the Dediabetes Evidence Intelligence™ framework.

What outcomes has Metformin been studied for?

outcomes studied
Emerging Evidence

HbA1c, Fasting Plasma Glucose (FPG), and Severe hypoglycemia are among the most studied areas in relation to Metformin.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Moderate | EvidenceScore™ 61.9 | moderate positive | ConsensusScore™ Consistent | 8 studies

  2. 2

    Fasting Plasma Glucose (FPG)

    EvidenceScore™ Emerging | EvidenceScore™ 57.3 | strong positive | ConsensusScore™ Consistent | 2 studies

  3. 3

    Severe hypoglycemia

    EvidenceScore™ Emerging | EvidenceScore™ 54.2 | strong positive | ConsensusScore™ Mixed | 1 study

Why this answer: This answer is based on 15 supporting studies and existing graph evidence signals.

Limitations

  • Consistency cannot yet be determined.
  • Population details are unavailable.
15 supporting studies14 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

Does Metformin improve HbA1c?

intervention outcome_effect
Moderate Evidence

Metformin may improve HbA1c.

ConsensusScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Moderate | EvidenceScore™ 61.9 | moderate positive | ConsensusScore™ Consistent | 8 studies

Why this answer: This answer is based on 8 supporting studies with consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
8 supporting studies7 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

Which outcomes have the strongest evidence for Metformin?

evidence strength
Emerging Evidence

HbA1c, Fasting Plasma Glucose (FPG), and Severe hypoglycemia have the strongest available evidence signals for Metformin.

ConsensusScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Moderate | EvidenceScore™ 61.9 | moderate positive | ConsensusScore™ Consistent | 8 studies

  2. 2

    Fasting Plasma Glucose (FPG)

    EvidenceScore™ Emerging | EvidenceScore™ 57.3 | strong positive | ConsensusScore™ Consistent | 2 studies

  3. 3

    Severe hypoglycemia

    EvidenceScore™ Emerging | EvidenceScore™ 54.2 | strong positive | ConsensusScore™ Mixed | 1 study

Why this answer: This answer is based on 10 supporting studies with consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
10 supporting studies9 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

Where does Metformin need more research?

research gaps
Emerging Evidence

Fasting Plasma Glucose (FPG), Severe hypoglycemia, and Systolic blood pressure need more research in relation to Metformin.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Fasting Plasma Glucose (FPG)

    EvidenceScore™ Emerging | EvidenceScore™ 57.3 | strong positive | ConsensusScore™ Consistent | 2 studies

  2. 2

    Severe hypoglycemia

    EvidenceScore™ Emerging | EvidenceScore™ 54.2 | strong positive | ConsensusScore™ Mixed | 1 study

  3. 3

    Systolic blood pressure

    EvidenceScore™ Emerging | EvidenceScore™ 54.2 | strong positive | ConsensusScore™ Unclear | 2 studies

Why this answer: This answer is based on 4 supporting studies and existing graph evidence signals.

Limitations

  • Consistency cannot yet be determined.
  • Population details are unavailable.
4 supporting studies4 RCTsUpdated: Jul 2026

How does Metformin compare across studied outcomes?

cross outcome_comparison
Emerging Evidence

HbA1c, Fasting Plasma Glucose (FPG), and Severe hypoglycemia have available evidence for Metformin, but the comparison requires review of the underlying studies.

ConsensusScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Moderate | EvidenceScore™ 61.9 | moderate positive | ConsensusScore™ Consistent | 8 studies

  2. 2

    Fasting Plasma Glucose (FPG)

    EvidenceScore™ Emerging | EvidenceScore™ 57.3 | strong positive | ConsensusScore™ Consistent | 2 studies

  3. 3

    Severe hypoglycemia

    EvidenceScore™ Emerging | EvidenceScore™ 54.2 | strong positive | ConsensusScore™ Mixed | 1 study

Why this answer: This answer is based on 10 supporting studies with consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
10 supporting studies9 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

Top outcomes affected

Outcome areas reported in the evidence summary.

Rank #1

HbA1c

EvidenceScore™
62/100
ConsensusScore™
Consistent
Direction: moderate positive
Studies: 8
Rank #2

Fasting Plasma Glucose (FPG)

EvidenceScore™
57/100
ConsensusScore™
Consistent
Direction: strong positive
Studies: 2
Rank #3

Severe hypoglycemia

EvidenceScore™
54/100
ConsensusScore™
Mixed
Direction: strong positive
Studies: 1

Strongest evidence relationships

Key patterns and insights identified across the research landscape

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

Moderate positive signal

HbA1c

Across 7 studies, Metformin shows a consistent moderate positive signal for HbA1c.

7 studies
EvidenceScore™: 61.9/100
View supporting studies
Strong positive signal

Fasting Plasma Glucose (FPG)

Across 2 studies, Metformin shows a consistent strong positive signal for Fasting Plasma Glucose (FPG).

2 studies
EvidenceScore™: 57.275/100
View supporting studies
Strong positive signal

HDL cholesterol

Across 1 study, Metformin shows a strong positive signal for HDL cholesterol.

1 studies
EvidenceScore™: 54.150000000000006/100
View supporting studies
Strong positive signal

LDL cholesterol

Across 1 study, Metformin shows a strong positive signal for LDL cholesterol.

1 studies
EvidenceScore™: 54.150000000000006/100
View supporting studies
Strong positive signal

Severe hypoglycemia

Across 1 study, Metformin shows a strong positive signal for Severe hypoglycemia.

1 studies
EvidenceScore™: 54.150000000000006/100
View supporting studies

Studies evaluating Metformin

Studies connected to this intervention in the evidence record.

Click outcomes and interventions to filter the archive when links are available.

Explore all Metformin evidence

Browse the complete evidence archive for this topic, including interventions, outcomes, and related research.

Explore all Metformin evidence

Filter by study type, publication date, effect size, and more to refine your research